View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 1, 2021

PENTAX and Vedkang form JV for endoscopic device development

To be based in China, PENTAX Medical Therapeutics will develop products for European, Asian and American markets. 

HOYA Group’s PENTAX Medical and Jiangsu Vedkang Medical Science and Technology have formed a joint venture (JV) to create single-use, flexible medical endoscopic therapeutic products.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The JV, named PENTAX Medical Therapeutics (Jiangsu), will leverage PENTAX’s marketing network to provide advanced single-use devices to clients globally. The offering will be reinforced by Vedkang’s production and research and development framework.

Medical flexible endoscopes and therapeutic devices are utilised in less-invasive procedures.

The devices could benefit patients, physicians and medical care systems by reducing the cost or complexity of procedures. This could also result in improved recovery time for patients.

PENTAX Medical global president Gerald Bottero said: “Our collaboration will support the fast-growing Endotherapy segment as new and innovative procedures achieve traction and penetration worldwide.

“Now PENTAX Medical, together with Vedkang, looks forward to offering integrated endoscopy solutions to our valued global customers.”

To be headquartered in China, PENTAX Medical Therapeutics intends to develop and market products for major markets in Europe, Asia and the Americas.

Jiangsu Vedkang Medical Science and Technology chairman and CEO Zhuang XiaoJing said: “PENTAX Medical has always been a valuable business partner to Vedkang, and we are delighted to continue our close relationship in this JV by pursuing further possibilities with doctors and patients across the world.”

Last month, PENTAX Medical Europe received CE mark for its latest single-use bronchoscope, PulmoONE, which offers high-quality care without risking the level of pulmonary care.

The working channel of PulmoONE offers up to 50% increased suction power for rapid and effective patient care. It also delivers greater sterility along with high definition (HD) visualisation, thereby widening its clinical uses beyond the traditional disposable scope, the company said.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network